image
Fennec Pharmaceuticals Inc. FENC
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 6.11
-4.3 %
$ 169 M
Market Cap
-300.5
P/E
INCOME STATEMENT
47.5 M REVENUE
123.69%
Growth Rates
1Year 123.69%
3Years 0.00%
5Years 0.00%
7Years 0.00%
10Years 0.00%
2.57 M OPERATING INCOME
120.11%
Growth Rates
1Year 120.11%
3Years 29.05%
5Years 17.05%
7Years 13.12%
10Years 11.21%
-70 K NET INCOME
99.56%
Growth Rates
1Year 99.56%
3Years 84.08%
5Years 64.70%
7Years 48.25%
10Years 29.08%
EFFICIENCY
Earnings Waterfall Fennec Pharmaceuticals Inc.
image
Revenue 47.5 M
Cost Of Revenue 3.18 M
Gross Profit 44.4 M
Operating Expenses 41.8 M
Operating Income 2.57 M
Other Expenses 2.64 M
Net Income -70 K
50m50m45m45m40m40m35m35m30m30m25m25m20m20m15m15m10m10m5m5m00(5m)(5m)48m(3m)44m(42m)3m(3m)(70k)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income

Income Statement

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Jun-2004 Jun-2003 Jun-2002 Jun-2001 Jun-2000
REVENUE
Revenue 47.5 21.3 1.5 0 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0.661 0.676
GROSS PROFIT
Cost Of Revenue 3.2 1.3 86 K 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 55.2 K 0
Gross Profit 44.4 20.0 1.4 0 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 55.2 K 0.676
OPERATING INCOME
Operating Expenses 41.8 32.8 24.0 17.2 18.1 13.0 10.4 7.0 2.9 1.9 2.9 1.9 3.6 3.4 4.6 2.8 13.9 14.2 19.1 18.3 9.4 6.7 4.0 2.7 1.6
Selling, General and Administrative Expenses 41.5 32.7 20.5 12.2 12.9 7.4 5.4 5.0 2.4 1.6 2.5 1.3 1.5 1.9 3.9 1.2 3.5 3.3 2.9 3.2 3.5 1.8 0.9 0.7 0.6
Research and Development Expenses 0.3 56 K 3.5 5.0 5.1 5.6 5.0 1.9 0.5 0.3 0.4 0.6 2.1 1.5 0.7 2.1 10.4 10.9 14.0 12.4 3.6 3.5 3.1 1.9 0.9
Operating Income 2.6 (12.8) (22.6) (17.2) (17.9) (13.0) (10.4) (7.0) (2.9) (1.9) (2.9) (1.9) (3.6) (3.4) (4.6) (3.2) (13.9) (14.2) (19.1) (18.3) (9.4) (6.7) (4.0) (2.6) (1.6)
PRE-TAX INCOME
Interest Income Expense 4.1 3.4 1.0 0.1 9 K 0 0 0 0 0 2 K 0 0 0 0 0 0 0 3 K 11 K (0.4) 0 0 0 0
Total Other Income (2.6) (3.3) (1.1) (0.1) (0.2) 0.2 0.5 95 K 82 K 1.3 0.7 3.8 (1.5) 8.1 (3.5) 0.2 0 0.9 (1.5) (4.0) (0.2) 79.4 K 0.3 0.2 8.31 K
Pre-Tax Income 71 K (16.0) (23.7) (17.3) (18.1) (12.8) (9.9) (7.0) (2.8) (0.7) (2.2) 1.8 (5.2) 4.7 (7.8) (3.0) (13.6) (13.4) (20.6) (21.5) (9.6) (6.7) (3.7) (2.5) (1.6)
NET INCOME
Tax Provision 0.4 0 1.1 0.1 (0.2) (0.3) (0.3) 47 K 8 K 3 K 2 K 2 K 25 K 43 K 7.8 3.0 13.6 13.4 (1.5) (2.3) (0.9) (0.5) 3.7 2.5 1.6
Net Income (0.4) (16.0) (24.8) (17.5) (17.9) (12.5) (9.9) (7.0) (2.8) (0.7) (2.2) 1.8 (5.2) 4.7 (7.8) (3.0) (13.6) (13.4) (19.1) (19.2) (8.7) (6.1) (3.7) (2.5) (1.6)
EPS 0.016 0.6 0.95 0.67 0.76 0.63 0.52 0.47 0.22 0.0609 0.22 0.19 0.63 0.59 1.11 0.98 4.43 4.78 16.7 20.4 15 19.9 19.3 20.1 2.98